Modis Therapeutics Competitors and Similar CompaniesClear all

Amicus Therapeutics's competitors and similar companies include VCANBIO.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
VCANBIO
VCANBIO
VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.
Founding Date
Founding Date
2002
Founding Date
1993
Type
Type
Public
Type
Public
Tags
Locations
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Locations
Tianjin, CN HQ
Employees
Employees
58415% increase
Employees
2,0149% decrease
Valuation ($)
Valuation ($)
3.4 b
Valuation ($)
1.4 b

Financial

Revenue (est.)
Revenue (est.)
$634.2m (FY, 2025)
Revenue (est.)
¥1.4b (FY, 2025)
Cost of goods
Cost of goods
$72.9m (FY, 2025)
Cost of goods
¥438.8m (FY, 2025)
Gross profit
Gross profit
$561.3m (FY, 2025)
Gross profit
¥993.4m (FY, 2025)
Net income
Net income
($27.1m) (FY, 2025)
Net income
¥103.5m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

VCANBIO
HQ
Tianjin, CN
Employees
2,014↓ 9% decrease

VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.

View company